> ## Content Index
> Fetch the complete content index at: https://www.thepeptidereview.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Semax vs. Selank: A Research Comparison
- URL: https://www.thepeptidereview.co/semax-vs-selank-a-research-comparison/
- Published: 2026-08-28T01:00:00.000Z
- Updated: 2026-09-15T01:18:22.000Z
- Author: michael burbano
- Tags: Mechanism Explainers

Semax and Selank are almost always mentioned in the same breath — two synthetic peptides from the same Russian research program, both stabilized the same way, both studied for the nervous system. That shared origin is exactly why they get confused. But they are different molecules, built from different natural precursors, and the published literature has examined them for different questions. This is a side-by-side research comparison. It makes no health, therapeutic, or performance claims.

## The one-sentence distinction

**Semax is a stabilized fragment of the hormone ACTH; Selank is a stabilized fragment of the immune peptide tuftsin.** That single difference — what natural molecule each was built from — is what drives everything else: their sequences, and the research questions each has attracted.

## Side by side

|                       | **Semax**                                                    | **Selank**                                    |
| --------------------- | ------------------------------------------------------------ | --------------------------------------------- |
| **Type**              | Synthetic heptapeptide                                       | Synthetic heptapeptide                        |
| **Sequence**          | Met-Glu-His-Phe-Pro-Gly-Pro                                  | Thr-Lys-Pro-Arg-Pro-Gly-Pro                   |
| **Built from**        | ACTH(4–7) fragment                                           | Tuftsin (an IgG fragment)                     |
| **Stabilizing tail**  | Pro-Gly-Pro                                                  | Pro-Gly-Pro                                   |
| **Origin**            | Institute of Molecular Genetics, Russian Academy of Sciences | Same institute, same program                  |
| **Research focus**    | Neurotrophic / melanocortin systems, BDNF                    | Anxiolytic / GABAergic, immunomodulation      |
| **Regulatory status** | Registered in Russia; no FDA/Western approval                | Registered in Russia; no FDA/Western approval |

## What they share

- **The same design trick.** Both start with a short natural peptide that degrades within minutes, and both add a **Pro-Gly-Pro** tail to slow that breakdown. This is the signature of the research program that produced them.
- **The same lab.** Both came out of the **Institute of Molecular Genetics of the Russian Academy of Sciences**.
- **The same regulatory picture.** Both are registered medicines in Russia and neighboring countries, and neither has been evaluated or approved by the FDA or comparable Western agencies. Most human-subject data is in Russian-language clinical journals; Western-accessible work is largely preclinical.
- **The same handling.** Both appear as either a lyophilized (freeze-dried) powder in a sealed vial or a pre-mixed nasal solution, and both are studied most via intranasal delivery.

## Where they diverge

The interesting part is not what they share — it's why the research communities around them ask different questions.

**Semax** traces to a fragment of **ACTH**, a melanocortin hormone. Its literature therefore leans toward **neurotrophic and melanocortin questions**: studies commonly measure **BDNF** (brain-derived neurotrophic factor) and its receptor, profile gene-expression changes in nervous tissue, and probe the melanocortin system — the ACTH fragment *without* the parent hormone's cortisol-releasing activity. If you read Semax research, you're mostly reading neuropharmacology. (Full detail in our [Semax overview](https://www.thepeptidereview.co/semax-research-background-and-overview).)

**Selank** traces to **tuftsin**, a fragment of the IgG antibody with a role in **immune signaling**. Its literature therefore splits along two lines its precursor predicts: **anxiolytic / GABAergic research** — behavioral models of anxiety and interactions with GABA and serotonin systems — and **immunomodulation**, examining cytokine- and interferon-related pathways. If you read Selank research, you're reading a mix of neuropharmacology and immunopharmacology. (Full detail in our [Selank overview](https://www.thepeptidereview.co/selank-research-background-and-overview).)

Both, notably, have also been examined for effects on **BDNF and gene expression** — one of the few direct overlaps in their research records, and a reason they're studied comparatively.

## "Which is better?" is the wrong question

A lot of online writing frames these as competitors, as if one is stronger. From a research standpoint that framing doesn't hold: they were built from different molecules to explore different biology, and **neither has an approved use** that a "better/worse" ranking could even refer to. The useful comparison is not *which wins* but *what each was designed to study* — Semax as a neurotrophic/melanocortin probe, Selank as an anxiolytic/immune probe. Any claim online that ranks them on human outcomes is running ahead of what the evidence supports.

## Evaluating a sample of either

The quality question is identical for both, because it's a chemistry question, not a compound question. For either peptide, look for:

1. **A third-party Certificate of Analysis tied to the specific lot** — referencing the lot number on the vial in hand.
2. **HPLC purity data** — ideally a single clean dominant peak at high purity; a cluster of smaller peaks signals byproducts or degradation.

Our guide on [how to read a Certificate of Analysis](https://www.thepeptidereview.co/how-to-read-a-coa) breaks down what each figure means, and [how to store peptides](https://www.thepeptidereview.co/how-to-store-peptides) covers why a sealed lyophilized vial outlasts any pre-mixed solution. Both [Semax](https://novaforgelabs.co/product.html?id=17&ref=thepeptidereview.co) and [Selank](https://novaforgelabs.co/product.html?id=18&ref=thepeptidereview.co) are supplied as research-use-only reference materials, each with a lot-specific Certificate of Analysis.

## Frequently asked questions

**Are Semax and Selank the same thing?**  
No. They share a design approach and a lab of origin, but they are different molecules with different sequences, different natural precursors (ACTH fragment vs. tuftsin), and different research literatures.

**Can you take them together?**  
This article describes research background only and makes no recommendation about use of any kind. Neither compound is an approved product for human use.

**Is either approved by the FDA?**  
No. Both are registered in Russia and a few neighboring countries; neither has Western regulatory approval or evaluation.

**Why are they always compared?**  
Because they came from the same research program, use the same stabilizing tail, and are both studied in the nervous system — so they're natural companions in the literature, despite their different origins.

## References

1. Ashmarin IP, et al. *Regulatory peptide analogs: design of Semax and Selank.* Institute of Molecular Genetics, Russian Academy of Sciences.
2. Dolotov OV, et al. "Semax regulates BDNF and trkB expression in the rat hippocampus." *Journal of the Neurological Sciences.*
3. Zozulya AA, et al. "Efficacy and mechanisms of the peptide anxiolytic Selank." *Zhurnal Nevrologii i Psikhiatrii.*
4. Kolomin T, Shadrina M, Slominsky P, Limborska S, Myasoedov N. "Transcriptional effects of Semax and Selank in the rodent brain." *Journal of Molecular Neuroscience.*

*References are provided for background reading and do not constitute endorsement of any use.*

---

*The Peptide Review publishes educational summaries of the scientific literature. Nothing here is medical advice, and nothing here describes a use for any product. Compounds discussed are reference materials for qualified in-vitro laboratory research only and are not drugs, supplements, or products for human or animal consumption.*

🧪 Free research tools

[COA Checker →](https://thepeptidereview.co/peptide-coa-checker/?ref=thepeptidereview.co) — audit a Certificate of Analysis & spot forged/recycled COAs

[Reconstitution Calculator →](https://thepeptidereview.co/peptide-reconstitution-calculator/?ref=thepeptidereview.co) — exact draw in units + mL, on a to-scale syringe

[Stability & Shelf-Life Estimator →](https://thepeptidereview.co/peptide-stability-shelf-life-estimator/?ref=thepeptidereview.co) — how integrity holds up in the freezer, fridge & at room temp

Research Use Only

### Source the compounds covered here

The reference materials discussed above are supplied for qualified in-vitro laboratory research only — third-party HPLC-tested with a Certificate of Analysis per lot.

[Browse tested research compounds →](https://novaforgelabs.co/?ref=thepeptidereview.co)

The Peptide Review is published with support from NovaForge Labs. See our [Disclosures](https://www.thepeptidereview.co/disclosures-disclaimer/).

Subscriber offer

### Get 20% off your first order

Subscribe to The Peptide Review and we will send your NovaForge Labs discount code, plus each new research breakdown as it is published. No spam.

[Subscribe for 20% off →](#/portal/signup)